Management of Endometrial Hyperplasia

← Back to document page

Management of Endometrial Hyperplasia Green-top Guideline No. 67. RCOG/BSGE Joint Guideline | February 2016. Management of Endometrial Hyperplasia This is the first edition of this is a joint guideline between the Royal College of Obstetricians and Gynaecologists (RCOG) and the British Society for Gynaecological Endoscopy (BSGE). Executive summary of recommendations What are the risk factors for Endometrial Hyperplasia ? P. Endometrial Hyperplasia is often associated with multiple identifiable risk factors and assessment should aim to identify and monitor these factors. How should Endometrial Hyperplasia be classified? The revised 2014 World Health Organization (WHO) classification is recommended. This separates Endometrial Hyperplasia into two groups based upon the presence of cytological atypia: (i). D. Hyperplasia without atypia and (ii) atypical Hyperplasia . What diagnostic and surveillance methods are available for Endometrial Hyperplasia ?

Management of Endometrial Hyperplasia This is the first edition of this guideline.This is a joint guideline between the Royal College of Obstetricians

  Endometrial, Hyperplasia, Endometrial hyperplasia